In this interview, Joe Belluck leads a discussion with Dr. Jeffrey Velotta, a leading thoracic surgeon and mesothelioma specialist from Kaiser Permanente in the Bay Area, about the complexity of treating mesothelioma. The conversation underscores a central reality of this rare and aggressive cancer: there is no one-size-fits-all treatment pathway. Instead, successful care depends on careful patient selection, multidisciplinary collaboration, and thoughtful sequencing of therapies.

From determining surgical eligibility to choosing the right sequence of therapies, every decision requires careful consideration.

Ultimately, the most effective care combines clinical expertise with collaboration and a deep understanding of each patient’s unique situation. As research continues to evolve, this personalized, multidisciplinary model remains the foundation for improving outcomes in mesothelioma care.

Jeffrey Velotta is a board-certified thoracic surgeon specializing in the treatment of lung cancer, mesothelioma, and other diseases of the chest. He is known for his expertise in minimally invasive and robotic-assisted surgical techniques, including advanced procedures such as pleurectomy and decortication for mesothelioma patients.

Learn more about Jeffrey Velotta, MD